ClinicalTrials.gg
RecruitingNCT07915830Updated Nov 4, 2026

Comparing Two Laparoscopic Techniques for Hernia Repair in Children

An interventional study of Laparoscopic Percutaneous Extraperitoneal Closure (LPEC) and Laparoscopic Intracorporeal Suture (LIS) in Inguinal Hernia, sponsored by Quaid-e-Azam Medical College. Recruiting at 1 site in Pakistan. Open to participants aged 1 Year to 15 Years. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by Quaid-e-Azam Medical College · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled May 2026, registered Oct 2026).
  • Started May 2026; still recruiting 5 months later.
Updated Nov 4, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
412
Allocation
Randomized
Ages
1 Year to 15 Years
Sex
All
01

Study summary

The purpose of this randomized controlled trial is to compare the outcomes of two laparoscopic techniques for repairing inguinal hernia in children: laparoscopic percutaneous extraperitoneal closure (LPEC) and laparoscopic intracorporeal suture (LIS). The study will be conducted in the Department of Pediatric Surgery, Bahawal Victoria Hospital, Bahawalpur, and will enroll children aged 1 to 15 years of either gender who have a unilateral or bilateral inguinal hernia and are planned for laparoscopic repair. Children with recurrent, incarcerated, or previously operated hernias, coagulopathy, undescended testes, major congenital abdominal anomalies, congenital heart disease, or cerebral palsy will be excluded.

Participants will be randomly assigned, using sealed opaque envelopes, to one of two groups. Group A will undergo LPEC, in which the hernia sac is closed extraperitoneally with a needle passed percutaneously around the internal inguinal ring under laparoscopic view. Group B will undergo LIS, in which sutures are placed and tied entirely within the abdominal cavity. All operations will be performed by a single surgical team trained in both techniques.

The main outcome is hernia recurrence at 3 months. Secondary outcomes are operating time, post-operative pain (FLACC score at 12 hours, assessed by a resident blinded to the technique), hospital stay, wound infection within 30 days, other intra- and post-operative complications, and time to return to full activity. Children will be followed weekly in the outpatient clinic and assessed for recurrence at 3 months.

The study hypothesizes that recurrence at 3 months is higher with the intraperitoneal (LIS) approach than with the extraperitoneal (LPEC) approach.

02

Conditions studied

  • Inguinal Hernia

Keywords

  • Pediatric inguinal hernia
  • Laparoscopic hernia repair
  • Laparoscopic percutaneous extraperitoneal closure
  • LPEC
  • Laparoscopic intracorporeal suture
  • Hernia recurrence
  • Postoperative pain
  • FLACC scale
  • Children
03

In context

Hernia, Inguinal

567 studies on the registry are indexed under Hernia, Inguinal; 80 are open to participants now.

This study's planned enrollment of 412 is above the median of 90 across 420 interventional studies indexed under Hernia, Inguinal.

Browse Hernia, Inguinal studies →

Lead sponsor

Quaid-e-Azam Medical College is the lead sponsor of 11 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 15 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • unilateral or bilateral inguinal hernia
  • planned to undergo laparoscopic hernia repair

Exclusion criteria

Exclusion Criteria:

  • recurrent hernia
  • hernia after previous abdominal surgery
  • incarcerated hernia
  • coagulopathy
  • Associated undescended testes
  • Major congenital abdominal anomalies
  • Children with congenital heart disease
  • Cerebral palsy.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
412 participants (estimated)

Study arms

  • Experimental
    Laparoscopic Percutaneous Extraperitoneal Closure (LPEC)

    Children with unilateral or bilateral inguinal hernia will undergo laparoscopic hernia repair by the LPEC technique under general anesthesia.

    Procedure: Laparoscopic Percutaneous Extraperitoneal Closure (LPEC)

  • Active comparator
    Laparoscopic Intracorporeal Suture (LIS)

    Children with unilateral or bilateral inguinal hernia will undergo laparoscopic hernia repair by the LIS technique under general anesthesia.

    Procedure: Laparoscopic Intracorporeal Suture (LIS)

Interventions

  • ProcedureLaparoscopic Percutaneous Extraperitoneal Closure (LPEC)

    A laparoscope will be inserted through the umbilicus, and a needle with suture is passed percutaneously around the internal inguinal ring under direct laparoscopic vision. The hernia sac (processus vaginalis) is ligated extraperitoneally without opening the inguinal canal.

  • ProcedureLaparoscopic Intracorporeal Suture (LIS)

    Sutures will be placed and tied entirely within the abdominal cavity under laparoscopic visualization, using needle holders and graspers with instrument knot-tying (square or slip knots).

06

What researchers measure

Primary outcomes

  1. Hernia recurrence

    Number and percentage of children with recurrence of inguinal hernia on the operated side, assessed by clinical examination at the outpatient follow-up visit.

    Time frame: From randomization till three months after surgery

Other outcomes

  1. Operating time

    Time in minutes from skin incision to wound closure, recorded by the operation theater nurse in-charge using a stopwatch.

    Time frame: From skin incision to wound closure on the day of surgery

  2. Post-operative pain

    Pain score on the FLACC scale (Face, Legs, Activity, Cry, Consolability; range 0 to 10, higher scores indicating more pain), assessed every 2 hours after surgery by a resident blinded to the surgical technique. The final score at 12 hours is used for analysis.

    Time frame: From skin closure to 12 hours after postoperatively

  3. Duration of hospital stay

    Number of days from the day of surgery to the day of discharge. Children are discharged when pain free and mobile, as per hospital protocol.

    Time frame: From the day of surgery to discharge within 1 to 3 days

  4. Surgical wound infection

    Number and percentage of children with surgical site infection, defined as signs of inflammation (fever, pain, redness), purulent discharge, or an organism identified from an aseptically obtained specimen from the surgical site.

    Time frame: From wound closure to Within 30 days after surgery

  5. Time to return to full activity

    Time in days taken to return to all previously performed activities, recorded at weekly outpatient follow-up visits.

    Time frame: From wound closure up to 3 months after surgery

07

Study locations

1 of 1 sites recruiting
  • Qauad-e-Azam Medical College
    Bahawalpur, Punjab Province 63100, Pakistan
    Recruiting
    • Fatima A Principal Investigator, MBBS · Contactiffat.fatima47@gmail.com · +92 321 6381440
    • Muhammad R Professor, FCPS · Contactmramzanbhutta@gmail.com · +92 333 6387466
    • Fatima A Principal Investigator, MBBS · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07915830
Lead sponsor
Quaid-e-Azam Medical College
Responsible party
Fatima Arshad (Principal Investigator, Quaid-e-Azam Medical College) — Principal investigator
First posted
Nov 4, 2026
Start date
May 12, 2026
Primary completion
Nov 11, 2026 (estimated)
Completion
Nov 11, 2026 (estimated)
Last update
Nov 4, 2026

Study contacts

Fatima A Principal Investigator, MBBS
Contact
iffat.fatima47@gmail.com
+92 321 6381440
Muhammad R Professor, FCPS
Contact
mramzanbhutta@gmail.com
+92 333 6387466
Muhammad R Professor, FCPS
study chair · Quaid-e-Azam Medical College

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion